AGIO
Agios Pharmaceuticals, Inc.
34.20$
-2.2%
vs. previous close
Closing price · As of: Sep 23, 2026
Statements
Income Statement
All figures per share in USD.
Tick rows to compare them in a chart (up to 4)
| Line item | 2011 | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 0.93 | 1.07 | 1.66 | 1.94 | 1.58 | 1.79 | 0.92 | 1.64 | 1.97 | 2.94 | 0.00 | 0.26 | 0.48 | 0.63 | 0.93 | |
| 1.61 | 1.75 | 4.09 | 3.51 | 3.79 | 5.63 | 6.28 | 0.02 | 0.02 | 0.27 | 0.31 | 0.03 | 0.17 | 0.07 | 0.20 | |
| 0.93 | -0.68 | 1.66 | 1.94 | 1.58 | 1.79 | 0.92 | 1.62 | 1.94 | -0.27 | -0.31 | 0.23 | 0.31 | 0.56 | 0.73 | |
| 1.34 | 1.75 | 3.54 | 2.98 | 3.79 | 5.63 | 6.28 | 5.94 | 6.85 | 3.06 | 4.25 | 5.11 | 5.19 | 5.20 | 5.77 | |
| 0.31 | 0.30 | 0.64 | 0.57 | 0.96 | 1.30 | 1.53 | 1.99 | 2.20 | 2.16 | 2.01 | 2.22 | 2.15 | 2.71 | 3.11 | |
| 1.64 | 2.06 | 4.18 | 3.55 | 4.75 | 6.92 | 7.81 | 7.93 | 9.05 | 4.60 | 5.95 | 7.33 | 7.35 | 7.91 | 8.88 | |
| -0.71 | -0.98 | -2.52 | -1.61 | -3.17 | -5.14 | -6.89 | -6.31 | -7.11 | -4.87 | -6.26 | -7.10 | -7.03 | -7.35 | -8.14 | |
| 0.01 | 0.00 | 0.00 | 0.01 | 0.03 | 0.06 | 0.13 | 0.29 | 0.25 | 0.26 | 0.01 | 0.23 | – | – | – | |
| -0.71 | -0.98 | -2.52 | -1.60 | -3.15 | -5.07 | -6.75 | -6.03 | -6.86 | -4.77 | -5.90 | -4.23 | -6.33 | 12.40 | -7.14 | |
| 0.31 | -0.12 | 0.04 | -0.01 | -0.01 | -0.15 | -0.14 | 0.57 | -0.25 | 0.11 | -32.72 | -2.87 | 0.12 | 0.76 | -0.02 | |
| -1.01 | -0.86 | -2.56 | -1.59 | -3.15 | -5.07 | -6.75 | -6.03 | -6.86 | -4.74 | 26.55 | -4.23 | -6.33 | 11.64 | -7.12 | |
| -0.68 | -0.93 | -2.43 | -1.57 | -3.08 | -4.99 | -6.75 | -6.19 | -6.58 | -4.50 | -5.59 | -4.07 | -6.21 | 12.50 | -7.05 |
Data as of: September 23, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.